Global Cardiovascular Devices Market - Growth, Trends and Forecasts (2017 - 2022)

The global cardiovascular devices market accounted for USD XX million in 2015 and is estimated to reach USD XX million in 2016. The market is projected to reach USD XX million by 2021, growing at a CAGR of X% from 2016 to 2021.



Drivers and Restraints



Currently, the global cardiovascular devices market is growing at a considerable rate, owing to factors such as rapid technological advances, increasing awareness of the population, high preference of minimally invasive procedures over conventional surgeries, and emerging economies. The key opportunities for this market are increasing product launches and a large number of mergers and acquisitions between cardiovascular devices manufacturing companies. However, lack of skilled professionals to operate the devices, stringent regulations & legislations, and a high cost of the devices & their maintenance are the key challenges faced by the market. These result in unfavorable market conditions for new players.



The massive untapped markets in the emerging countries are creating a lot of opportunities for the global cardiovascular devices market, which is expected to grow at a considerable rate during the forecast period.



Market segmentation



The global cardiovascular devices market is segmented by -



1. Type:





Cardiac Rhythm Management Devices

Interventional Cardiac Devices

Automated External Defibrillators (AED)

Cardiac Ablation Catheters

Cardiac Pacemakers

Cardiac Angioplasty Devices

Implantable Cardioverter Defibrillators (ICD)

Prosthetics (Artificial) Heart Valves

Stents

Ventricular Assist Devices





Stents hold a prominent share in its segment due to the rising demand of minimally invasive surgeries (MIS) for the treatment of coronary artery disease.



2. Technology:





Cardiopulmonary Bypass Products

Minimally Invasive Cardiac Surgery

Valve Prosthesis & Repair

Cardiac Assist Devices





The market is segmented by geography into North America, Europe, Asia-Pacific and Rest of the World. North America had the highest market share in 2015, owing to the increasing adoption of advanced surgical treatments and presence of a large pool of target population. The U.S leads the North American market, followed by Canada. Asia-Pacific represents the fastest growing region for global cardiovascular devices, due to the growing geriatric population and increasing awareness about various cardiovascular devices.







Key Players



Some of the largest market players in the cardiovascular devices market are -





Abbott Vascular

Boston Scientific Corporation

Cordis

Edwards Life Science

GE Healthcare

Gore Medical

Medtronic

Numed

SIEMENS Healthcare

St. Jude Medical

Toshiba





Key Deliverables in the Study





Market analysis for the global cardiovascular devices market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers, restraints opportunities and challenges.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.

Identification and analysis of the macro and micro factors that affect the global cardiovascular devices market.

Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.



1. INTRODUCTION



1.1 Study Deliverables



1.2 Market Definition



1.3 Sizing Units



1.4 Base Currency



1.5 Review and Forecast Period Years



1.6 General Study Assumptions



1.7 Report Description



2. RESEARCH METHODOLOGY



2.1 Introduction



2.2 Analysis Methodology



2.3 Study timeline



2.4 Study Phases



2.4.1 Secondary Research



2.4.2 Discussion Guide



2.4.3 Market Engineering & Econometric Model



2.4.4 Expert Validation



3. EXECUTIVE SUMMARY



4. KEY INFERENCES



5. MARKET OVERVIEW AND INDUSTRY TRENDS



5.1 Current Market Scenario



5.2 Porters Five Forces Analysis



5.2.1 Bargaining Power of suppliers



5.2.2 Bargaining Power of Buyers



5.2.3 Degree of Competition



5.2.4 Threat of Substitution



5.2.5 Threat of New Entrants



6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)



6.1 Market Drivers



6.1.1 Rapid Technological Advances to Boost the Market Growth



6.1.2 Increasing Awareness Among the Population



6.1.3 Increased Preference of Minimally Invasive Procedures Over Conventional Surgeries



6.1.4 Emerging Economies Present Significant Growth Opportunities



6.2 Market Restraints



6.2.1 Different Regulatory Policies Delaying the Product Launches



6.2.2 Expensive Instruments & Maintenance



6.2.3 Unfavorable Market Conditions for New Players



6.3 Market opportunities



6.3.1 Increasing Product Launches



6.3.2 Increase in Mergers and Acquisitions



6.4 Key Challenges



6.4.1 Lack of Skilled Professionals to Operate Devices



6.4.2 Stringent Regulations and Legislations



6.4.3 High Cost for The Devices



7. GLOBAL TUMOR ABLATION MARKET -SEGMENTATION



7.1 By Type



7.1.1 Cardiac Rhythm Management Devices



7.1.2 Interventional Cardiac Devices



7.1.3 Automated External Defibrillators (AED)



7.1.4 Cardiac Ablation Catheters



7.1.5 Cardiac Pacemakers



7.1.6 Cardiac Angioplasty Devices



7.1.7 Implantable Cardioverter Defibrillators (ICD)



7.1.8 Prosthetics (Artificial) Heart Valves



7.1.9 Stents



7.1.10 Ventricular Assist Devices



7.2 By Technology



7.2.1 Cardiopulmonary Bypass Products



7.2.2 Minimally Invasive Cardiac Surgery



7.2.3 Cardiac Assist Devices



7.2.4 Valve Prosthesis & Repair



8. Global Cardiovascular Devices market by Geography - Regional Shares and Forecast



8.1 North America



8.1.1 United States



8.1.2 Canada



8.1.3 Mexico



8.2 Europe



8.2.1 Germany



8.2.2 UK



8.2.3 France



8.2.4 Italy



8.2.5 Spain & Portugal



8.2.6 Scandinavia



8.2.7 Benelux



8.2.8 Rest of Europe



8.3 Asia-Pacific



8.3.1 China



8.3.2 Japan



8.3.3 India



8.3.4 Australia & New Zealand



8.3.5 South Korea



8.3.6 Rest of Asia-Pacific



8.4 The Middle East and Africa



8.4.1 GCC



8.4.2 South Africa



8.4.3 Rest of the Middle East and Africa



8.5 Latin America



8.5.1 Brazil



8.5.2 Argentina



8.5.3 Rest of Latin America



9. Competitive Landscape



9.1 Merger and Acquisition Analysis



9.2 New Product Launches



9.3 Agreements, Collaborations & Partnerships



10. Company Profiles



10.1 Abbott Vascular



10.2 Boston Scientific Corporation



10.3 Cordis



10.4 Edwards Life Science



10.5 GE Healthcare



10.6 Gore Medical



10.7 Medtronic



10.8 Numed



10.9 SIEMENS Healthcare



10.10 St.Jude Medical



10.11 Toshiba



11. Analyst Outlook for Investment Opportunities



12. Future Outlook of the Market

Content are not available

Choose License Type